Keyphrases
Acetamido
9%
Arachidonic Acid
9%
ATP Concentration
18%
ATP Release
100%
Benzoate
9%
Beta-blockers
9%
Biosensor Techniques
9%
Block Volume
9%
Carboxylate
9%
Cell Surface
18%
Cell Volume
9%
Channel Blocker
18%
Cl Channel
100%
Concentration-dependent
18%
Cystic Fibrosis Transmembrane Conductance Regulator
100%
Early Treatment
9%
Epithelial Cell Line
100%
Extracellular Concentration
9%
Gd3+
9%
Glibenclamide
9%
Human Epithelial Cells
100%
Hypotonic Challenge
9%
Intestine
18%
Luciferase Assay
9%
Luciferin
9%
Nitro
9%
Osmolality
9%
Osmotic Swelling
27%
P2X Receptors
9%
PC12 Cells
9%
Purinergic Receptors
9%
Release Pathway
9%
Stilbene Derivatives
9%
Stretch-activated Channels
9%
Sub-inhibitory Concentration
9%
Swelling-induced
100%
Trivalent Lanthanides
9%
Whole Cell
9%
Neuroscience
Adenosine Triphosphate
100%
Arachidonic Acid
6%
Benzoate
6%
Benzoic Acid
6%
Carboxylic Acid
6%
Cell Line
100%
Channel Blocker
13%
Chloride Channel
100%
Cystic Fibrosis Transmembrane Conductance Regulator
100%
Epithelial Cells
100%
Glibenclamide
6%
Luciferase
6%
Luciferin
6%
Purinergic P2X2 Receptor
6%
Purinergic Receptor
6%
Pharmacology, Toxicology and Pharmaceutical Science
5 Nitro 2 (3 Phenylpropylamino)benzoic Acid
6%
Adenosine Triphosphate
100%
Arachidonic Acid
6%
Carboxylate
6%
Channel Blocker
13%
Chloride Channel
100%
Cystic Fibrosis Transmembrane Conductance Regulator
100%
Glibenclamide
6%
Lanthanide
6%
Luciferase
6%
Luciferin
6%
Purinergic P2X2 Receptor
6%
Purinergic Receptor
6%
Stilbene Derivative
6%